Admin

New gas ramping function enables world’s first in vitro reproduction of ischaemia/reperfusion conditions in a microplate reader

Aug 15, 2017

BMG LABTECH reports successful development of new technology within the MetaCell-TM project Ortenberg, Germany (August 2017) – BMG LABTECH developed a new gas ramping function that can fully manipulate the environment within a microplate reader, by mimicking in vitro hypoxia and ischaemia/reperfusion. Equipped with this unique feature, the CLARIOstar® with Atmospheric Control Unit (ACU) is the first plate reader that is able to rapidly return to physiological gas conditions upon active modification of oxygen (02) and carbon dioxide (CO2) tensions within the reader, reproducing disease-specific settings in live cell-based assays. The use of conditions that resemble as close as possible ...

Read More

Dr. Christian Fischer to be appointed CEO of Gerresheimer AG

Aug 15, 2017

Duesseldorf –  Dr. Christian Fischer (53) will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking over as Chief Executive Officer on September 1, 2017. Dr. Christian Fischer is currently President, Performance Chemicals, at BASF SE in Ludwigshafen, Germany. Uwe Röhrhoff (54), CEO of Gerresheimer AG, previously announced in November 2015 that he would not be available to serve on the Management Board beyond his current appointment. “In Dr. Christian Fischer, we have gained an outstanding leader as CEO. He brings with him 24 years of industry experience and has demonstrated his ...

Read More

Herbal medicine shows potential to treat cancer

Aug 11, 2017

Researchers from King Abdullah University of Science and Technology (KAUST) have been searching locally for plants that have potential for use to combat cancer. Now, three plants used for traditional medicine in Saudi Arabia are shown to be worthy of further investigation for anticancer properties. Cancer is a leading cause of illness and death worldwide. In 2015, the World Health Organization (WHO) recorded 8.8 million cancer-related deaths, but almost twice as many cases are diagnosed each year. And the WHO predict that the number of cancer diagnoses is likely to continue to increase by about 70% for at least the ...

Read More

Diabetes drug shows potential as disease-modifying therapy for Parkinson’s disease

Aug 11, 2017

A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson’s disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety. The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), found that people with Parkinson’s who injected themselves each week with exenatide for one year performed better in movement (motor) tests than those who injected a placebo. “This is a very promising finding, as the drug holds potential to affect the course of the disease itself, and not merely the ...

Read More

Roche reports strong performance in the first half of 2017

Aug 11, 2017

In the first half of 2017, Group sales rose 5% to CHF 26.3 billion. Core EPS grew 6%, ahead of sales. Core EPS growth reflects the strong underlying business performance. IFRS net income increased 2%. Sales in the Pharmaceuticals Division increased 5% to CHF 20.5 billion. The recently launched medicines Tecentriq, Ocrevus and Alecensa contributed CHF 0.5 billion of new sales, which represents half of the division’s growth. Perjeta continued its strong sales increase. This growth was partially offset by lower sales of Tarceva, Tamiflu and Pegasys. In the US, sales advanced 8%, led by Tecentriq, Xolair, MabThera/Rituxan and Ocrevus, ...

Read More